Cannabis prohibition isn’t ending because of the massive profits to be made growing and selling the plant. Or because the war on cannabis is racist, oppressive, counterproductive, and an astounding waste of resources. Or because cannabis is far safer than alcohol. Or because George Washington used to grow hemp. We’re creating an economy around the […]
David Bienenstock
Posts by 'David Bienenstock'
The following compendium of landmark cannabis studies is exclusively focused on top-level research that either fundamentally advanced our understanding of the plant’s therapeutic properties, or thoroughly debunked some pernicious piece of official misinformation—such as “smoking weed gives you lung cancer.” But that’s only half the story when it comes to the intersection of science and […]
Like most Americans of my generation, I first encountered Canadian cannabis in the early-1990s, courtesy of what came to be known as “Beasters.” Although many now look back on Beasters with snobbish disdain (the term itself has become something of a put down), at the time they were a big step up from the Mexican […]
Despite mountains of anecdotal evidence pointing to serious therapeutic benefits, there’s little hard data on cannabis as a treatment for post-traumatic stress disorder (PTSD). But after a decade-long battle between researchers and the DEA, the first-ever randomized controlled study of the efficacy of cannabis for military veterans with PTSD is currently underway, with cannabis supplied […]
Here’s another paradox: Anyone seeking out obscure cannabis strains of the distant past—far flung exotic landraces that never made a commercial impact to begin with, or the hottest new hybrids that haven’t yet hit the commercial market—will like have better luck dusting off their old underground dealer rolodex and chasing after leads and clues like […]
As Canada works towards next year’s launch of an adult-use cannabis market, there are still some key regulatory issues to hammer out. One of which is how the country should handle its existing medical marijuana program. A pair of pharmacology researchers at Dalhousie University in Halifax, Nova Scotia, want to see officials separate medical and […]
As Canada works towards next year’s launch of an adult-use cannabis market, there are still some key regulatory issues to hammer out. One of which is how the country should handle its existing medical marijuana program. A pair of pharmacology researchers at Dalhousie University in Halifax, Nova Scotia, want to see officials separate medical and […]
